51047-52-0 Usage
Uses
Used in Pharmaceutical Synthesis:
4-(Piperazin-1-yl)pyriMidine is used as a key building block for the creation of various pharmaceutical drugs. Its unique structure allows for the development of molecules with specific biological activities, making it an essential component in medicinal chemistry.
Used in Organic Chemistry Research:
In the field of organic chemistry, 4-(Piperazin-1-yl)pyriMidine is utilized as a precursor in the synthesis of a wide range of organic compounds. Its reactivity and chemical properties facilitate the exploration of new synthetic pathways and the discovery of novel chemical entities.
Used in Medicinal Chemistry Research:
4-(Piperazin-1-yl)pyriMidine is employed as a starting material in the design and synthesis of biologically active molecules. Its potential pharmacological activity has been studied, and it serves as a valuable tool for the development of new therapeutic agents.
Used in Drug Discovery:
4-(Piperazin-1-yl)pyriMidine is used as a chemical probe in drug discovery processes. Its incorporation into various molecular frameworks can lead to the identification of new drug candidates with improved efficacy and selectivity for targeted biological pathways.
Check Digit Verification of cas no
The CAS Registry Mumber 51047-52-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,0,4 and 7 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 51047-52:
(7*5)+(6*1)+(5*0)+(4*4)+(3*7)+(2*5)+(1*2)=90
90 % 10 = 0
So 51047-52-0 is a valid CAS Registry Number.
51047-52-0Relevant academic research and scientific papers
Modified amino acids, pharmaceuticals containing these compounds and method for their production
-
, (2008/06/13)
The present invention relates to modified amino acids of general formula wherein A, Z, X, n, m, R, R2, R3, R4 and R11 are defined as in claims 1 to 5, their tautomers, their diastereomers, their enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, the use thereof and processes for preparing them as well as their use for the production and purification of antibodies and as labelled compounds in RIA- and ELISA assays and as diagnostic or analytical aids in neurotransmitter research.
Substituted pyrimidine derivatives and their pharmaceutical use
-
, (2008/06/13)
PCT No. PCT/GB97/02029 Sec. 371 Date Feb. 12, 1999 Sec. 102(e) Date Feb. 12, 1999 PCT Filed Jul. 25, 1997 PCT Pub. No. WO98/06705 PCT Pub. Date Feb. 19, 1998This invention concerns heterocyclic derivatives which are useful in inhibiting oxido-squalene cyclase, processes for their preparation and pharmaceutical compositions containing them. The present invention is also concerned with heterocyclic derivatives capable of inhibiting cholesterol biosynthesis and hence in lowering cholesterol levels in blood plasma. The present invention also relates to methods of using such heterocyclic derivatives in diseases and medical conditions such as hypercholesterolemia and atherosclerosis.
